Clinical Trial: Semaglutide in CFRD
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cystic Fibrosis
Study Type: INTERVENTIONAL
Official Title: Efficacy and Safety of GLP-1 Agonist Therapy in Overweight and Obese Subjects With Cystic Fibrosis-related Diabetes: a Pilot Study
Brief Summary:
This open label, single arm pilot study, will examine the safety and tolerability of GLP-1RA semaglutide as an add-on therapy to insulin for overweight/obese adult patients with cystic fibrosis related diabetes (CFRD).
Read more